What is the application principle of diodes in ophthalmic surgical instruments?

1, Optoelectronic conversion and energy output: the core working mechanism of diodes
The diode achieves photoelectric conversion through the PN junction of semiconductor materials. When current passes through, electrons and holes recombine and release energy, emitting laser light of a specific wavelength in the form of photons. The commonly used diode laser in ophthalmic surgery uses gallium aluminum arsenide (GaAlAs) as the working substance, emitting wavelengths concentrated in the near-infrared range of 780nm to 850nm. The selection of this band is based on two major technological advantages:

High electro-optical conversion efficiency: The electro-optical conversion efficiency of diode lasers can reach 50%, which is much higher than that of argon ion lasers (about 10%) and Nd: YAG lasers (about 30%). This means that under the same input power, diodes can output higher energy density lasers to meet the needs of surgical tissue cutting or solidification.
Compact structure and low energy consumption: The diode laser adopts a solid-state design and does not require an external circulation cooling system. It only needs air cooling to operate stably. For example, the IRIS Oculight SLX system outputs laser through a G-fiber probe, which is only one-third the volume of traditional laser equipment, making it easy to operate flexibly under a surgical microscope.
2, Wavelength selection and tissue penetration: the key to precise targeting
Ophthalmic surgery requires extremely strict selection of laser wavelength, taking into account both penetration depth and tissue absorption characteristics. The 780nm-850nm wavelength range of diode lasers exhibits three major advantages in clinical practice:

Strong scleral penetration: This wavelength laser can penetrate 35% of the scleral thickness (second only to 1064nm Nd: YAG laser), but the scleral absorption rate is only 6%, while the absorption rate of ciliary pigment tissue is as high as three times that of Nd: YAG laser. This characteristic makes it the preferred light source for transcranial ciliary body photocoagulation (TSCPC) - laser energy can penetrate the sclera directly to the ciliary process, destroy pigment epithelial cells through thermal effects, reduce aqueous humor production, and thus lower intraocular pressure.
Retinal protection: Unlike argon ion laser (488nm-514nm), which is easily absorbed by the cornea and lens and causes thermal damage, diode laser's near-infrared light can penetrate the refractive interstitium and directly act on the retinal pigment epithelium layer. For example, in the treatment of retinopathy of prematurity, 810nm laser is output through an indirect ophthalmoscope system with a spot diameter of 600 μ m and a power of 300-600mW, which can accurately coagulate abnormal blood vessels without damaging the retinal nerve fiber layer.
Hemoglobin absorption peak matching: The 810nm band is close to the absorption peak of hemoglobin (805nm), allowing laser energy to be efficiently absorbed by hemoglobin in blood vessels and converted into thermal energy to seal blood vessels. This feature is particularly important in the treatment of diabetes retinopathy - laser can selectively coagulate leaking microaneurysms, while reducing damage to normal retinal tissue.
3, Organizational interaction mechanism: balance between thermal and photochemical effects
The interaction between diode laser and eye tissue is mainly achieved through thermal effects, and its depth of action is closely related to energy density

Thermal coagulation effect: When the laser energy density reaches the tissue degeneration threshold (about 2.7 J/point), the ciliary process pigment epithelial cells undergo coagulative necrosis, the stromal layer blood vessels are occluded, and the ciliary muscle contraction ability decreases. For example, in TSCPC surgery, using a laser with a power of 2.6W and an exposure time of 1.5-2.5 seconds can form a coagulation spot with a diameter of 500 μ m in the ciliary process, effectively reducing intraocular pressure by 30% -50%.
Photothermal control technology: To avoid excessive thermal damage, modern diode laser systems adopt pulse mode and energy feedback control. For example, the EOS 3000 system focuses the laser beam through a micro lens to minimize the spot area, while adjusting the energy output through the explosive sound of tissue reactions to ensure precise control of the energy density at each condensation point within a safe range.
Photochemical effect assistance: Under low energy density (<1J/point), diode laser can induce retinal pigment epithelial cells to release cytokines, promoting degeneration of diseased blood vessels. This mechanism has been applied in Subthreshold Diode Micropulse Photocoagulation (SDM), where the 810nm laser's micropulse mode (5% duty cycle) effectively controls macular edema while avoiding retinal scar formation.
4, Device Integration Design: Transformation from Laboratory to Clinical
The popularization of diode laser in ophthalmic surgery cannot be separated from the breakthrough of equipment integration technology:

Fiber optic coupling technology: Transmitting laser through single-mode or multi-mode fiber optic to achieve miniaturization of surgical probes. For example, the URAME2 ophthalmic endoscopic system integrates an intraocular probe with a diameter of 0.89mm and an 810nm diode laser, which can directly perform photocoagulation on retinal tears during vitrectomy, with a field of view range of 70 ° and a focal depth of 0.5-7.0mm.
Multi modal imaging guidance: Modern ophthalmic laser systems often integrate OCT (Optical Coherence Tomography) or wide-angle fundus imaging modules to achieve real-time and accurate alignment between laser spots and lesion areas. For example, in the treatment of diabetes retinopathy, doctors can locate microaneurysms through OCT images, and then target coagulation through diode lasers to control the treatment error within 50 μ m.
Intelligent energy management system: Energy prediction algorithms based on big data can automatically adjust laser parameters according to the characteristics of the patient's eye tissue, such as sclera thickness and pigment content. For example, a certain model of diode laser system analyzed 100000 surgical data through machine learning, reducing the incidence of complications in TSCPC surgery from 19% to 5%, and increasing the success rate of intraocular pressure reduction to 76%.
5, Clinical Application Case: From Glaucoma to Retinopathy
Glaucoma treatment: Diode laser TSCPC has become the standard treatment for refractory glaucoma. A multicenter study involving 248 patients showed that TSCPC surgery with 2.6W power, 500 μ m spot, and 360 ° irradiation had a success rate of 70% in reducing intraocular pressure within one year, and only 3% of patients experienced complications of low intraocular pressure, significantly better than traditional cryotherapy (success rate of 55%, complication rate of 25%).
Retinopathy of premature infants: 810nm diode laser output through an indirect ophthalmoscope system can perform 360 ° photocoagulation on the retina of premature infants with stage 3 plus lesions. Clinical data shows that this regimen can cause 93% of pediatric lesions to regress, with only 2% experiencing pre retinal hemorrhage, far superior to cryotherapy (78% lesion regression rate and 12% retinal detachment rate).
Diabetes retinopathy: SDM technology forms subclinical photocoagulation spots in the macular region through the micro pulse mode of 810nm laser, effectively reducing macular edema without damaging visual function. A randomized controlled trial showed that the visual acuity improvement rate of patients in the SDM treatment group reached 65%, while the traditional photocoagulation group was only 40%.